Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)

NCT01817582 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Keratoconjunctivitis Sicca

Interventions

DRUG: Lotemax
DRUG: Restasis
DRUG: Soothe® Lubricant Eye Drops

Sponsor

Bausch & Lomb Incorporated

Collaborators

[object Object]